CD44-engineered mesoporous silica nanoparticles for overcoming multidrug resistance in breast cancer-Reference-Cited by-同舟云学术

CD44-engineered mesoporous silica nanoparticles for overcoming multidrug resistance in breast cancer

Published:2015-03 Issue: Volume:332 Page:308-317
ISSN:0169-4332
Container-title:Applied Surface Science
language:en
Short-container-title:Applied Surface Science

Author:

Wang Xin,Liu Ying,Wang Shouju,Shi Donghong,Zhou Xianguang,Wang Chunyan,Wu Jiang,Zeng Zhiyong,Li Yanjun,Sun Jing,Wang Jiandong,Zhang Longjiang,Teng Zhaogang,Lu Guangming

Funder

National 973 Program

National Science Foundation of China

Jiangsu Technology Foundation

Jiangsu Postdoctoral Fund Project

Publisher

Elsevier BV

Subject

Surfaces, Coatings and Films,Condensed Matter Physics,Surfaces and Interfaces,General Physics and Astronomy,General Chemistry

Reference55 articles.

1. Breast cancer statistics, 2013;Desantis;CA Cancer J. Clin.,2014

2. Reversal of multidrug resistance by stimuli-responsive drug delivery systems for therapy of tumor;Yin;Adv. Drug Deliv. Rev.,2013

3. Reversion of multidrug resistance in tumor by biocompatible nanomaterials;Zhang;Mini Rev. Med. Chem.,2010

4. Enhanced chemotherapy of cancer using pH-sensitive mesoporous silica nanoparticles to antagonize P-glycoprotein-mediated drug resistance;Huang;Mol. Cancer Ther.,2011

5. Overcoming multidrug resistance in human cancer cells by natural compounds;Nabekura;Toxins (Basel),2010

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Harnessing the synergistic potential of NK1R antagonists and selective COX-2 inhibitors for simultaneous targeting of TNBC cells and cancer stem cells;Journal of Drug Targeting;2024-02

2. A paradigm use of monoclonal antibodies-conjugated nanoparticles in breast cancer treatment: current status and potential approaches;Journal of Drug Targeting;2023-12-28

3. Mesoporous silica nanoparticles: An emerging approach in overcoming the challenges with oral delivery of proteins and peptides;Colloids and Surfaces B: Biointerfaces;2023-12

4. Current advances in nanoformulations of therapeutic agents targeting tumor microenvironment to overcome drug resistance;Cancer and Metastasis Reviews;2023-07-28

5. Antibody-Functionalized Nanoparticles for Targeted Drug Delivery in Cancer Therapy;Handbook of Cancer and Immunology;2023